ORCHARD THERAPEUTICS PLC.

In News

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome - Yahoo Finance

Yahoo Finance - Jul 07, 2025

Charity bringing to EU market gene therapy spurned by pharma - bioworld.com

bioworld.com - Nov 14, 2025

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - GlobeNewswire

GlobeNewswire - Dec 02, 2025

Orchard Therapeutics plc (NASDAQ:ORTX) - intelligentinvestor.com.au

intelligentinvestor.com.au - Dec 25, 2025

ORTX Stock Price, News & Analysis - Stock Titan

Stock Titan - Apr 25, 2025

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - pharmaceutical-technology.com

pharmaceutical-technology.com - Jan 25, 2024

Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin - slaughterandmay.com

slaughterandmay.com - Oct 05, 2023

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - gsk.com

gsk.com - Apr 12, 2018

Orchard sets out to sell world’s priciest gene therapy - biopharmadive.com

biopharmadive.com - Mar 20, 2024

Orchard to lose out on milestone payments as Pharming Group ends collab - The Business Journals

The Business Journals - May 08, 2024

Orchard Therapeutics PLC (ORTX) Reports Q3 2023 Earnings and Announces Acquisition by Kyowa Kirin - Yahoo Finance

Yahoo Finance - Nov 13, 2023

Orchard turns to layoffs in cutting gene therapy research - biopharmadive.com

biopharmadive.com - Mar 30, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment